Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease (original) (raw)

Nature Genetics volume 46, pages 352–356 (2014)Cite this article

Subjects

Abstract

Nonalcoholic fatty liver disease (NAFLD) is the most common form of liver disease. To elucidate the molecular basis of NAFLD, we performed an exome-wide association study of liver fat content. Three variants were associated with higher liver fat levels at the exome-wide significance level of 3.6 × 10−7: two in PNPLA3, an established locus for NAFLD, and one (encoding p.Glu167Lys) in TM6SF2, a gene of unknown function. The TM6SF2 variant encoding p.Glu167Lys was also associated with higher circulating levels of alanine transaminase, a marker of liver injury, and with lower levels of low-density lipoprotein–cholesterol (LDL-C), triglycerides and alkaline phosphatase in 3 independent populations (n > 80,000). When recombinant protein was expressed in cultured hepatocytes, 50% less Glu167Lys TM6SF2 protein was produced relative to wild-type TM6SF2. Adeno-associated virus–mediated short hairpin RNA knockdown of Tm6sf2 in mice increased liver triglyceride content by threefold and decreased very-low-density lipoprotein (VLDL) secretion by 50%. Taken together, these data indicate that TM6SF2 activity is required for normal VLDL secretion and that impaired TM6SF2 function causally contributes to NAFLD.

This is a preview of subscription content, access via your institution

Access options

Subscribe to this journal

Receive 12 print issues and online access

$259.00 per year

only $21.58 per issue

Buy this article

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Additional access options:

Similar content being viewed by others

Accession codes

Primary accessions

NCBI Reference Sequence

References

  1. Tiniakos, D.G., Vos, M.B. & Brunt, E.M. Nonalcoholic fatty liver disease: pathology and pathogenesis. Annu. Rev. Pathol. 5, 145–171 (2010).
    Article CAS Google Scholar
  2. Browning, J.D. et al. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 40, 1387–1395 (2004).
    Article Google Scholar
  3. McCullough, A.J. The clinical features, diagnosis and natural history of nonalcoholic fatty liver disease. Clin. Liver Dis. 8, 521–533, viii (2004).
    Article Google Scholar
  4. Romeo, S. et al. Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease. Nat. Genet. 40, 1461–1465 (2008).
    Article CAS Google Scholar
  5. Speliotes, E.K. et al. Genome-wide association analysis identifies variants associated with nonalcoholic fatty liver disease that have distinct effects on metabolic traits. PLoS Genet. 7, e1001324 (2011).
    Article CAS Google Scholar
  6. Yuan, X. et al. Population-based genome-wide association studies reveal six loci influencing plasma levels of liver enzymes. Am. J. Hum. Genet. 83, 520–528 (2008).
    Article CAS Google Scholar
  7. Chambers, J.C. et al. Genome-wide association study identifies loci influencing concentrations of liver enzymes in plasma. Nat. Genet. 43, 1131–1138 (2011).
    Article CAS Google Scholar
  8. Victor, R.G. et al. The Dallas Heart Study: a population-based probability sample for the multidisciplinary study of ethnic differences in cardiovascular health. Am. J. Cardiol. 93, 1473–1480 (2004).
    Article Google Scholar
  9. Gorden, A. et al. Genetic variation at NCAN locus is associated with inflammation and fibrosis in non-alcoholic fatty liver disease in morbid obesity. Hum. Hered. 75, 34–43 (2013).
    Article CAS Google Scholar
  10. Hernaez, R. et al. Association between variants in or near PNPLA3, GCKR, and PPP1R3B with ultrasound-defined steatosis based on data from the Third National Health and Nutrition Examination Survey. Clin. Gastroenterol. Hepatol. 11, 1183–1190 e2 (2013).
    Article CAS Google Scholar
  11. Stender, S., Frikke-Schmidt, R., Nordestgaard, B.G. & Tybjaerg-Hansen, A. Extreme bilirubin levels as a causal risk factor for symptomatic gallstone disease. JAMA Intern. Med. 173, 1222–1228 (2013).
    Article CAS Google Scholar
  12. Teslovich, T.M. et al. Biological, clinical and population relevance of 95 loci for blood lipids. Nature 466, 707–713 (2010).
    Article CAS Google Scholar
  13. Kathiresan, S. et al. Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans. Nat. Genet. 40, 189–197 (2008).
    Article CAS Google Scholar
  14. Kathiresan, S. et al. Common variants at 30 loci contribute to polygenic dyslipidemia. Nat. Genet. 41, 56–65 (2009).
    Article CAS Google Scholar
  15. Krogh, A., Larsson, B., von Heijne, G. & Sonnhammer, E.L. Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes. J. Mol. Biol. 305, 567–580 (2001).
    Article CAS Google Scholar
  16. Marchler-Bauer, A. et al. CDD: a Conserved Domain Database for the functional annotation of proteins. Nucleic Acids Res. 39, D225–D229 (2011).
    Article CAS Google Scholar
  17. Kaliannan, K. et al. Intestinal alkaline phosphatase prevents metabolic syndrome in mice. Proc. Natl. Acad. Sci. USA 110, 7003–7008 (2013).
    Article CAS Google Scholar
  18. Friedewald, W.T., Levy, R.I. & Fredrickson, D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative centrifuge. Clin. Chem. 18, 499–502 (1972).
    CAS PubMed Google Scholar
  19. Szczepaniak, L.S. et al. Measurement of intracellular triglyceride stores by H spectroscopy: validation in vivo. Am. J. Physiol. 276, E977–E989 (1999).
    CAS PubMed Google Scholar
  20. Price, A.L. et al. Principal components analysis corrects for stratification in genome-wide association studies. Nat. Genet. 38, 904–909 (2006).
    Article CAS Google Scholar
  21. Folch, J., Lees, M. & Sloane Stanley, G.H. A simple method for the isolation and purification of total lipides from animal tissues. J. Biol. Chem. 226, 497–509 (1957).
    CAS Google Scholar
  22. Chen, Z. et al. AAV8-mediated long-term expression of human LCAT significantly improves lipid profiles in hCETP;Ldlr+/− mice. J. Cardiovasc. Transl. Res. 4, 801–810 (2011).
    Article Google Scholar

Download references

Acknowledgements

We thank F. Xu for excellent technical assistance. This work was supported by grants from the US National Institutes of Health (HL20948, 1HL092550 and DK090066) and the National Center for Advancing Translational Sciences (UL1TR001105). T.F.V. acknowledges the contributions of G. Gao (University of Massachusetts) for advice and assistance with AAV vector production.

Author information

Author notes

  1. Julia Kozlitina and Eriks Smagris: These authors contributed equally to this work.

Authors and Affiliations

  1. McDermott Center for Human Growth and Development, University of Texas Southwestern Medical Center, Dallas, Texas, USA
    Julia Kozlitina, Eriks Smagris, Helen H Hobbs & Jonathan C Cohen
  2. Department of Clinical Biochemistry, Rigshospitalet, Copenhagen University Hospital and Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
    Stefan Stender & Anne Tybjærg-Hansen
  3. Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital and Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
    Børge G Nordestgaard & Anne Tybjærg-Hansen
  4. Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital and Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
    Børge G Nordestgaard
  5. Copenhagen City Heart Study, Frederiksberg Hospital, Copenhagen University Hospital and Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
    Børge G Nordestgaard & Anne Tybjærg-Hansen
  6. Merck Research Laboratories, Kenilworth, New Jersey, USA
    Heather H Zhou & Thomas F Vogt
  7. Howard Hughes Medical Institute, University of Texas Southwestern Medical Center, Dallas, Texas, USA
    Helen H Hobbs

Authors

  1. Julia Kozlitina
  2. Eriks Smagris
  3. Stefan Stender
  4. Børge G Nordestgaard
  5. Heather H Zhou
  6. Anne Tybjærg-Hansen
  7. Thomas F Vogt
  8. Helen H Hobbs
  9. Jonathan C Cohen

Contributions

The manuscript was prepared by all of the authors. E.S. and H.H.Z. performed the experiments. J.K. and S.S. performed the genetic analysis and association studies. T.F.V., A.T.-H., B.G.N., J.C.C. and H.H.H. provided experimental design and coordination.

Corresponding authors

Correspondence toHelen H Hobbs or Jonathan C Cohen.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Integrated supplementary information

Supplementary Figure 1 Short hairpin RNA–mediated knockdown of Tm6sf2 in mice.

(a) AAV vector alone or AAV expressing an shRNA against mouse Tm6sf2 mRNA were injected into the tail veins of 8-week-old chow-fed C57Bl/6J male mice (n = 5/group). After 2 weeks, the mice were killed and the liver, white adipose tissue (WAT) and small intestine were harvested. Levels of Tm6sf2 mRNA were measured using real-time PCR and normalized to m36B4 levels. The differences in mean expression levels were compared using a two-sample t test. (b) AAV expressing three different shRNAs or AAV vector alone were injected intravenously into 8-week-old chow-fed C57Bl/6J male mice (n = 6/group). All three shRNAs were directed against mouse Tm6sf2, but only shRNA8 knocked down the levels of Tm6sf2 mRNA with high efficiency in cultured cells. Two weeks after the injection, mice were fasted for 4 h, the livers were harvested, and the levels of Tm6sf2 mRNA were measured using real-time PCR. Values were normalized to m36B4 and expressed relative to the mean value of the AAV-only treated mice. Plasma was collected in the same experiment, and triglyceride and cholesterol levels were measured as described in the Online Methods. Differences in mean expression levels were compared using two-sample t tests. C_t_, cycle threshold value.

Supplementary information

Source data

Rights and permissions

About this article

Cite this article

Kozlitina, J., Smagris, E., Stender, S. et al. Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease.Nat Genet 46, 352–356 (2014). https://doi.org/10.1038/ng.2901

Download citation

This article is cited by